Health Condition 1: L700- Acne vulgaris
Conditions
Interventions
Intervention1: Adapalene 0.1 percentage: A third generation topical retinoid to be used once daily at night in a pea sized quantity approximately 250 milligrams over the lesions for a period of 8 we
Sponsors
Self
Eligibility
Inclusion criteria
Inclusion criteria: Patients with mild to moderate acne according to global acne grading system and those who give informed consent ad are willing for follow up
Exclusion criteria
Exclusion criteria: Patients with severe acne , other variants of acne and drug induced acne . Patients who have used oral medications in the past one month and are not willing to give informed consent and follow up. Patients who are pregnant, lactating mother and who exhibit clinical signs of PCOS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the reduction in total acne lesion count including both inflammatory and non inflammatory lesions from baseline to 8 weeksTimepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the proportion of patients achieving greater than 75 percentage and greater than 50 percentage reduction in total acne lesion count between the two treatment groups. To compare the change in global acne grading system score from baseline to 8 weeks following treatment between two groups. Assess the severity and incidence of local adverse effects and overall tolerability of each drug. To compare the incidence and severity of local adverse effects and overall tolerability between two treatment groupsTimepoint: 1 year 6 months | — |
Countries
India
Contacts
Public ContactDr Kannan G
Vinayaka Missions Kirupananda Variyar Medical College and Hospital
Outcome results
None listed